Abstract

A CLINICAL EVALUATION ON THE EFFECT OF VIRECHANA KARMA IN SWITRA W.S.R. TO LEUCODERMA

Dr. Roopam Singh*, Dr. Vikram Gupta and Dr. Piyush Gupta

Abstract

Introduction: Leucoderma (Switra) is a hypo pigmentation dermatological disorder involving body and mind, where patient feels socially and emotionally deranged by which it effect’s the appearance and outlook of the individual. It has also become a social stigma. Though disorder is non-contagious but it is often source of social embarrassment. Patients often isolate themselves from the fear of rejection from the society. In Ayurveda, prognosis, management of Switra has been described in detail. Lots of research work has been done at various institutes of Ayurveda. With the aim of providing better relief to the patient, this study was planned and aim of this proposed study was to clinically evaluate the effect of Virechana Karma in Switra w.s.r. to Leucoderma. Methods: The research study is performed with Shaman Sneha by which their effects were evaluated with the help of clinical study. Total 30 patients were diagnosed as Switra (Leucoderma) of any socio- economic status, age group of 10 to 60 years and irrespective of sex of all ethnic origins were randomly selected. 15 patients were with Switra from less than 1 year and 15 patients were with switra from more than 1 year. For assessment, subjective parameters as Twak-shwetata (white patches), twakrukshta( dryness), daha(burning sensation), roma- vidwamsa(changes in colour of hair) and objective parameters as no. of Virechana Vega, time taken to start Virechana, time of last Virechana Vega, condition during Vegas, effect on signs and symptoms, were taken. Result: Group A: Complete improvement- NIL, marked improvement- 6.67%, moderate improvement- 86.66%, mild improvement- 6.67%, unchanged improvement- NIL. Group B:- Complete improvement- NIL, marked improvement- NIL, moderate improvement- 40%, mild improvement- 60%, unchanged improvement- NIL. According to the above shown results, group A has shown better effect on patients as compared to group B.

Keywords: Switra, Leucoderma, Virechana, Shamana Sneha.